Total Funding
84
49
Total FundingCorporate Round raised
Growth Score 84 in past quarter
-5 pts
Heat Score 49 in past quarter
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
81301
Highly differentiated, best-in-class pain relief drugs for surgical and dental procedures
- Mark Sebree: Board Director & CDO
About the Company
Balanced Pharma is advancing best-in-class anesthetic and analgesic drugs. Pipeline assets include Enduracaine, a non-opioid, injectable local analgesic, intended to lower post-surgical pain (orthopedic, oral & maxillofacial, gynecological, podiatry, etc. surgeries), and Libracaine Dental, an injectable local dental anesthetic intended to
reduce injection pain, take effect faster, and increase the odds of effective anesthesia.